Last reviewed: July 11, 2026
Last updated: July 11, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Tirzepatide (the active ingredient in Mounjaro) works by triggering insulin release when blood glucose rises, which means it carries hypoglycemia risk—especially in patients already taking diabetes medications. Understanding how tirzepatide affects blood sugar regulation and when to pause or adjust dosing is essential for safe weight loss therapy.
How Tirzepatide Affects Blood Sugar Levels
Tirzepatide activates both GLP-1 and GIP receptors on pancreatic beta cells, signaling them to release insulin only when blood sugar is elevated. This glucose-dependent mechanism is different from older insulin secretagogues, which release insulin regardless of blood glucose level. The result is that tirzepatide alone rarely causes dangerously low blood sugar in people without diabetes medications.
The medication also slows stomach emptying and increases feelings of fullness, reducing overall calorie intake. Both mechanisms combine to lower average blood glucose over time. In clinical trials, tirzepatide demonstrated sustained A1C reductions of 1.5 to 2.5 percentage points in people with type 2 diabetes who were not on insulin.
Hypoglycemia Risk Factors When Using Tirzepatide
The greatest hypoglycemia risk occurs when tirzepatide is combined with other medications that lower blood sugar, particularly insulin, sulfonylureas (like glyburide or glipizide), or meglitinides. If you take any of these drugs, your prescribing physician may reduce your doses as tirzepatide begins working. Do not stop or adjust diabetes medications on your own—medical supervision is required.
People with a personal history of recurrent low blood sugar, irregular eating patterns, or very high baseline insulin doses face elevated risk even on tirzepatide alone. A prior diagnosis of hypoglycemia unawareness (inability to feel low blood sugar symptoms) requires extra vigilance. PlexusDx medical professionals screen for these risk factors during your initial consultation.
Recognizing Low Blood Sugar Symptoms While on Tirzepatide
Mild hypoglycemia symptoms include shakiness, sweating, rapid heartbeat, anxiety, hunger, and tingling around the mouth. These typically appear when blood glucose drops below 70 mg/dL (3.9 mmol/L). Most people can self-treat by consuming 15 grams of fast-acting carbohydrates—juice, glucose tablets, or regular soda—and rechecking blood sugar after 15 minutes.
Severe hypoglycemia causes confusion, difficulty speaking, loss of consciousness, or seizures and requires immediate emergency care or glucagon injection. Keep a glucagon kit on hand if you have diabetes or a strong hypoglycemia history. Report any low blood sugar episodes to your PlexusDx provider immediately, as dose or medication adjustments may be necessary.
Monitoring and Safety When Starting Tirzepatide Injections
Before beginning tirzepatide therapy at PlexusDx, you'll undergo a medical review including fasting blood glucose, A1C, and a complete medication list. If you take diabetes medications, your provider will discuss whether dose reductions are needed before or during tirzepatide treatment. Home blood glucose monitoring is strongly recommended for the first 4-8 weeks.
PlexusDx compounded tirzepatide injections start at $249 per month across all commitment tiers—your dose may need to go up, but your price won't. The Precision Peptide Genetic Test ($99 add-on after your first month) identifies genetic variants in the GLP1R and other glucose-regulation pathways, helping predict your individual response and hypoglycemia sensitivity. This personalized data guides your healthcare team in optimizing dosing and monitoring frequency.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I take tirzepatide if I have diabetes and take insulin?
Yes, but only under medical supervision. Tirzepatide can be combined with insulin, but your insulin dose typically needs to be reduced to prevent low blood sugar. PlexusDx providers review all your medications before starting therapy and monitor blood glucose closely during the first weeks of treatment.
Is tirzepatide safer for low blood sugar than other GLP-1 drugs?
Tirzepatide and other GLP-1 agonists have glucose-dependent insulin secretion, meaning they trigger insulin only when blood sugar is high—a major safety advantage over older diabetes drugs. Both tirzepatide and semaglutide carry similar low hypoglycemia risk when used alone, but tirzepatide may cause slightly more blood sugar lowering due to its dual GIP+GLP-1 action.
What does PlexusDx's Precision Peptide Genetic Test reveal about my hypoglycemia risk?
The test analyzes 14 metabolic pathways including GLP1R rs6923761 and other variants affecting glucose sensing and insulin secretion sensitivity. These genetic insights help predict whether you may be a fast responder (higher hypoglycemia risk) or slow responder, allowing your PlexusDx provider to adjust starting dose and monitoring frequency accordingly.
How much does tirzepatide cost at PlexusDx?
PlexusDx compounded tirzepatide injections start at $249 per month. Your dose may need to increase over time for better results, but your monthly price remains flat—no per-dose fees or hidden tier jumps. All medications are sourced from licensed 503A compounding pharmacies and are HSA/FSA eligible.
What should I do if I experience low blood sugar while on tirzepatide?
Consume 15 grams of fast-acting carbohydrates immediately and check blood glucose after 15 minutes. If symptoms don't resolve or recur, call emergency services or use glucagon if available. Report all low blood sugar episodes to your PlexusDx provider to determine if dose adjustment is needed.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mounjaro First Month Results: What to Expect
Where to Buy Mounjaro for Weight Loss: A Comprehensive Guide